Turnover: 181 million EUR (2020)

Country: Switzerland

The Ypsomed Group is a leading developer and manufacturer of injection and infusion systems for self-medication, and a renowned diabetes specialist with over 30 years' experience.

Ypsomed Delivery Systems (YDS) provides a comprehensive range of technologies and services for reliable, user-friendly injection systems for self-medication. Its customers are pharmaceutical and biotech companies that develop, manufacture and market injectable therapies.

With its mylife Diabetescare brand (CHF 315 million in 2017), Ypsomed offers a comprehensive portfolio of products and services for people with diabetes.

Financial Data

DUNS: 449734631

Legal Name: YPSOMED

Address: 44 RUE LA FAYETTE , 75009 PARIS 9

Number of employees: 1800 ()

Capital: 1 000 000 EUR


Financial Data:

Year Turnover (€) Net Profit (€) Fiscal Year End Fiscal Year Duration
2019 34 026 509 EUR 358 537 EUR 31/03/2019 12
2018 60 903 333 EUR 2 276 480 EUR 31/03/2018 12
2017 32 125 695 EUR 1 282 892 EUR 31/03/2017 12
2016 11 659 159 EUR 215 929 EUR 31/03/2016 12

Studies mentioning this company

The Insulin Pump Market - France

Other companies mentioned:

  • Medtronic
  • Cellnovo
  • Roche Diabetes Care (Roche Groupe)
  • Insulet
  • Ypsomed Group
  • ISIS diabète (Isis Médical)
  • Physidia
  • Nova Medical Center
  • Medtrum
  • Apex Wellell
  • Open APS
  • Eli Lilly
  • TreeFrog Therapeutics
  • Boydsense

> Besoin de plus d'information sur cette entreprise (SWOT, PESTEL, son marché) ? Demandez à SectorGPT (gratuit)

 

Ask Sector-GPT  

Sector-GPT est la première IA dédiée aux informations sectorielles.